Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (471-480 of 664) with videos related to

Pageof 67
Sort By:
The Journal of Biological Chemistry|June 4, 2015
Biological Relevance and Therapeutic Potential of the Hypusine Modification SystemNora Pällmann, Melanie Braig, Henning Sievert, et al.
Molecular Cancer Therapeutics|March 12, 2009
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancerMarcus M Schittenhelm, Christian Kollmannsberger, Karin Oechsle, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer CellsSergey A Dyshlovoy, Dmitry N Pelageev, Lea S Jakob, et al.
Haematologica|December 18, 2009
Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cellsDjordje Atanackovic, York Hildebrandt, Adam Jadczak, et al.
Proteomics|April 27, 2017
Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalininSergey A Dyshlovoy, Katharina Otte, Simone Venz, et al.
Clinical & Experimental Metastasis|April 10, 2012
VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinomaAlexander Schultze, Isabel Ben Batalla, Sabine Riethdorf, et al.
British Journal of Cancer|April 14, 2022
RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminomaChristine Hjorth Andreassen, Mette Lorenzen, John E Nielsen, et al.
Frontiers in Immunology|October 25, 2023
Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells <i>in vitro</i>Franziska Brauneck, Leticia Oliveira-Ferrer, Jana Muschhammer, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2012
Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancerTobias J Grob, Tobias Hoenig, Till S Clauditz, et al.
Blood|December 8, 2009
The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphomaEva Maria Murga Penas, Evelyne Callet-Bauchu, Hongtao Ye, et al.
Pageof 67

Showing results (471-480 of 664) with videos related to

Sort By:
Pageof 67
The Journal of Biological Chemistry|June 4, 2015
Biological Relevance and Therapeutic Potential of the Hypusine Modification SystemNora Pällmann, Melanie Braig, Henning Sievert, et al.
Molecular Cancer Therapeutics|March 12, 2009
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancerMarcus M Schittenhelm, Christian Kollmannsberger, Karin Oechsle, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer CellsSergey A Dyshlovoy, Dmitry N Pelageev, Lea S Jakob, et al.
Haematologica|December 18, 2009
Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cellsDjordje Atanackovic, York Hildebrandt, Adam Jadczak, et al.
Proteomics|April 27, 2017
Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalininSergey A Dyshlovoy, Katharina Otte, Simone Venz, et al.
Clinical & Experimental Metastasis|April 10, 2012
VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinomaAlexander Schultze, Isabel Ben Batalla, Sabine Riethdorf, et al.
British Journal of Cancer|April 14, 2022
RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminomaChristine Hjorth Andreassen, Mette Lorenzen, John E Nielsen, et al.
Frontiers in Immunology|October 25, 2023
Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells <i>in vitro</i>Franziska Brauneck, Leticia Oliveira-Ferrer, Jana Muschhammer, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2012
Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancerTobias J Grob, Tobias Hoenig, Till S Clauditz, et al.
Blood|December 8, 2009
The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphomaEva Maria Murga Penas, Evelyne Callet-Bauchu, Hongtao Ye, et al.
Pageof 67